Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/65752
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2020-12-15T10:02:26Z-
dc.date.available2020-12-15T10:02:26Z-
dc.date.issued2020-
dc.identifier.citationGrixti, D. J., Montefort, S., Grech, L., & Azzopardi, L. M. (2020). Pharmacists’ interventions in COPD related hospital readmissions. American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting & Exhibition.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/65752-
dc.description.abstractExacerbation of COPD defined as acute worsening of respiratory symptoms is associated with accelerated disease progression, often leading to hospitalisations impacting patients’ quality of life, mortality, and morbidity, and national healthcare systems. A key component in the management of COPD is prevention of exacerbations (GOLD, 2020) 1 which are not only of significant detriment to the patient but consume a considerable portion of healthcare expenditure. The Centre for Disease Control and Prevention estimate that by 2020 COPD expenditure will increase to $49 billion. 2 The European Respiratory Society reported that the annual cost of respiratory disease in the EU zone amounts to over €380 billion of which €48 billion can be attributed to COPD related healthcare and lost productivity costs. 3 Previous studies conducted in Malta focused on different aspects of COPD management other than on understanding factors responsible for increased risk of exacerbations necessitating hospitalisation. The rationale of this research is formulated on an attempt to identify variables contributing towards exacerbation of COPD which lead to hospitalisation whilst highlighting the contribution of the pharmaceutical service provision. The acute general teaching hospital, Mater Dei Hospital which is the main public hospital of the Maltese islands provided the research setting. The hospital offers inpatient and outpatient services in addition to specialised clinics including respiratory clinics.en_GB
dc.language.isoenen_GB
dc.publisherUniversity of Malta. Department of Pharmacyen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectHospitals -- Admission and dischargeen_GB
dc.subjectHospital utilizationen_GB
dc.subjectLungs -- Diseases, Obstructive -- Patientsen_GB
dc.subjectLungs -- Diseases, Obstructive -- Treatmenten_GB
dc.titlePharmacists’ interventions in COPD related hospital readmissionsen_GB
dc.typepresentationen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.bibliographicCitation.conferencenameAmerican Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting & Exhibitionen_GB
dc.bibliographicCitation.conferenceplace6-10/12/2020en_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorGrixti, Daniel Joseph-
dc.contributor.creatorMontefort, Stephen-
dc.contributor.creatorGrech, Louise-
dc.contributor.creatorAzzopardi, Lilian M.-
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Pharmacists’ interventions in COPD related hospital readmissions.pdf385.92 kBAdobe PDFView/Open


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.